R&D Collaborations
Nucleonics maintains several sponsored research collaborations with researchers based in leading life science research foundations and at several academic institutions. These research collaborations are integral to the advancement of Nucleonics eiRNA therapeutic programs and enable Nucleonics to efficiently access world class scientific insight that is relevant to its product development programs. The company currently maintains research collaborations with the following institutions:
  • Brown University
  • California Pacific Medical Center
  • Columbia University Medical Center
  • Drexel University
  • Georgetown University
  • International Center for Genetic Engineering and Biotechnology
  • Lankenau Institute for Medical Research
  • The Hepatitis B Foundation
  • The Scripps Research Foundation
  • University of Illinois at Chicago
  • University of the Sciences in Philadelphia
Nucleonics welcomes opportunities to evaluate scientific discoveries and technologies that might be useful in furthering its eiRNA therapeutics programs. Inquires may be addressed to:
Nucleonics, Inc.
Office of Technology Affairs
702 Electronic Drive
Horsham, PA 19044
Partnerships
Currently all of Nucleonics preclinical and clinical programs are available for partnering. It is Nucleonics intention to develop its initial clinical candidates through Phase IIa clinical trials and then partner the product candidates with appropriately positioned partners for pivotal Phase III clinical trials and ultimately product launch.
Nucleonics, Inc.
Program Partnering
702 Electronic Drive
Horsham, PA 19044